Presented by

BPCI BPCI
IPHA IPHA
NIBRT NIBRT

Event sponsors

McKesson McKesson
PwC PwC

Agency partners

Enterprise Ireland Enterprise Ireland
IDA Ireland IDA Ireland
InterTrade Ireland InterTrade Ireland
Science Foundation Ireland Science Foundation Ireland

Manufacturing workshop presented by NIBRT

Manufacturing next-generation biologics
Venue: NIBRT, UCD Fosters Avenue, Mount Merrion, Dublin
9:00
Delegate registration
Tour of NIBRT's cell and gene therapy capability
10:00
Global status of ATMP manufacture
Tom Bannon, Associate Director, Biologics and Advanced Therapies SME, PM Group
10:30
How Ireland can develop cell and gene therapy manufacturing
Dominic Carolan, Chief Executive Officer, NIBRT
11:00
Evaluating biomanufacturing expansion: build vs. buy dilemma
Beth Webb, Commercial GM, Cell and Gene Therapy, GE Healthcare Life Sciences
11:30
Avectas: engineering next-generation ex vivo cell therapies
Dr Shirley O’Dea, Founder and Director, Avectas
12:00
Networking lunch
12:45
The regulatory perspective
Grainne Power, Director of Human Products Authorisation and Registration, HPRA
13:15
Shedding light on inherited eye disorders: elucidating causes, developing gene therapies
Professor Jane Farrar, Professor of Genetics, Trinity College Dublin
13:45
Case study: Takeda cell therapy at Grange Castle, Dublin
Sebastian Wehle, Head of Stem Cell Manufacturing and Supply, Takeda Ireland
14:15
Panel Discussion
15:00
Tour of NIBRT's cell and gene therapy capability
Close